In conclusion, our study suggests that specific epidemiologic and clinicopathologic characteristics were associated with KRAS and BRAFV600E mutations in a large cohort of Chinese colorectal carcinoma population. The gene discussed is KRAS; the disease is colorectal carcinoma.